par de Azambuja, Evandro
;Zardavas, Dimitros
;Lemort, Marc
;Rossari, José
;Moulin, C;Buttice, A;D'Hondt, Veronique
;Lebrun, Fabienne;Lalami, Yassine
;Cardoso, Fatima
;Sotiriou, Christos
;Gil, Thierry
;Devriendt, Daniel
;Paesmans, M.;Piccart-Gebhart, Martine
;Awada, Ahmad 
Référence Annals of oncology, 24, 12, page (2985-2989)
Publication Publié, 2013-12












Référence Annals of oncology, 24, 12, page (2985-2989)
Publication Publié, 2013-12
Article révisé par les pairs
Résumé : | Brain metastases (BMs) pose a clinical challenge in breast cancer (BC). Lapatinib or temozolomide showed activity in BM. Our study assessed the combination of both drugs as treatment for patients with HER2-positive BC and BM. |